BAUSCH LOMB STAKE BUY

TPG, Blackstone bid for Bausch + Lomb in potential $14 billion deal

The spin-off of Bausch + Lomb has been stalled due to concerns that losing its more profitable subsidiary could leave Bausch Health insolvent, given its $21 billion debt load. Major lenders, including Apollo Management, Elliott Management, GoldenTree Asset Management, and Silver Point Capital, have opposed the spin-off.